Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Alexion Pharmaceuticals Company Profile (NASDAQ:ALXN)

Consensus Ratings for Alexion Pharmaceuticals (NASDAQ:ALXN) (?)
Ratings Breakdown: 4 Hold Rating(s), 11 Buy Rating(s)
Consensus Rating:Buy (Score: 2.73)
Consensus Price Target: $210.86 (25.42% upside)

Current Analysts' Coverage Summary for Alexion Pharmaceuticals (NASDAQ:ALXN)
Show:
DateFirmActionRatingPrice TargetActions
5/18/2015Morgan StanleyReiterated RatingEqual Weight$185.00 -> $177.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2015BarclaysReiterated RatingOverweight$225.00 -> $205.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2015SunTrustReiterated RatingBuy$236.00 -> $246.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015Citigroup Inc.Set Price TargetHold$208.00 -> $173.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015NomuraUpgradeNeutral -> Buy$222.00 -> $246.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015Brean CapitalLower Price TargetBuy$215.00 -> $213.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Piper JaffrayReiterated RatingOverweight$214.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015OppenheimerInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015Jefferies GroupBoost Price TargetHold$164.00 -> $167.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2015BTIG ResearchReiterated RatingBuy$250.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/30/2015Leerink SwannBoost Price TargetOutperform$200.00 -> $224.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/30/2015Stifel NicolausBoost Price TargetBuy$230.00 -> $236.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2014JPMorgan Chase & Co.Reiterated RatingOverweight$220.00 -> $225.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/1/2014Bank of AmericaInitiated CoverageBuy$197.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2014Credit SuisseInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2014Robert W. BairdBoost Price Target$175.00 -> $199.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2014Deutsche BankBoost Price TargetBuy$125.00 -> $205.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/31/2014Canaccord GenuityBoost Price TargetBuy$161.00 -> $200.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2014Goldman SachsDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/25/2013GuggenheimBoost Price TargetBuy$127.00 -> $130.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/25/2013Cowen and CompanyBoost Price TargetOutperform$115.00 -> $123.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/28/2013 forward)